Biobeat

Biobeat is a med-tech company founded in 2016 that develops wearable remote patient monitoring solutions for the healthcare continuum. The company offers two main devices: a disposable short-term chest monitor and a long-term wrist monitor. Both utilize proprietary photoplethysmography-based (PPG) sensor technology to continuously and non-invasively measure up to 13 health parameters, including cuffless blood pressure, pulse rate, respiratory rate, blood oxygen saturation, temperature, stroke volume, cardiac output, and one-lead ECG (chest monitor only). Biobeat's devices were the first to receive FDA clearance for cuffless non-invasive blood pressure monitoring from PPG alone. As of March 2022, the company's wearables were cleared by the FDA to monitor five key vital signs: blood pressure, blood oxygen saturation, pulse rate, respiratory rate, and body temperature. In January 2023, Biobeat received additional FDA clearance to monitor stroke volume and cardiac output.

The company's cloud-based patient management platform aggregates patient health data and includes an automated real-time early warning score system with AI-based algorithms to alert medical staff about patient health status and potential deterioration. This allows healthcare providers to support tailored patient care, adjust therapeutics, and prevent disease exacerbations. Biobeat's solutions are designed for use in hospitals, long-term care facilities, and home settings. The company's wearable devices are CE Mark certified.